Therapeutic Potential of Vasoactive Intestinal Peptide and its Receptors in Neurological Disorders

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 9, Iss. 5, 2010-11 ,pp. : 661-666

Bentham Science Publishers

Access to resources Recommend Favorite

Vasoactive intestinal peptide family as a therapeutic target for Parkinson’s disease

By Gonzalez-Rey Elena   Chorny Alejo   Fernandez-Martin Amelia   Varela Nieves   Delgado Mario  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 5, 2005-10 ,pp. : 923-929

Informa Healthcare

Access to resources Recommend Favorite

Potential Applications of Vasoactive Intestinal Peptide-Based Therapies on Transplantation

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 12, Iss. 4, 2012-12 ,pp. : 333-343

Bentham Science Publishers

Access to resources Recommend Favorite

Calcitonin Gene-Related Peptide: Vasoactive Effects and Potential Therapeutic Role

By Brain S.D.   Cambridge H.  

General Pharmacology, Vol. 27, Iss. 4, 1996-06 ,pp. : 607-611

Elsevier

Access to resources Recommend Favorite

Editorial [Hot Topic: Vasoactive Intestinal Peptide (VIP): Historic Perspective and Future Potential]

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 12, Iss. 4, 2012-12 ,pp. : 303-307

Bentham Science Publishers

Access to resources Recommend Favorite